Evidence map›Paper›PMID 40143200›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.

Glory Adebayo, Opeyemi I Ayanda, Matthias Rottmann, Olusola S Ajibaye, Gbolahan Oduselu, Julius Mulindwa, Olayinka O Ajani, Oluwagbemiga Aina, Pascal Mäser, Ezekiel Adebiyi

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Glory AdebayoCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota PMB 1023, Nigeria.
Opeyemi I AyandaDepartment of Biological Sciences, College of Science and Technology, Covenant University, Ota PMB 1023, Nigeria.
Matthias RottmannSwiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland.
Olusola S AjibayeBiochemistry and Nutrition Division, Nigerian Institute of Medical Research, Yaba PMB 2013, Nigeria.ORCID 0000-0002-3888-2366
Gbolahan OduseluCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota PMB 1023, Nigeria.
Julius MulindwaDepartment of Biochemistry and Sports Science, College of Natural Sciences, Makerere University, Kampala P.O. Box 7062, Uganda.
Olayinka O AjaniCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota PMB 1023, Nigeria.ORCID 0000-0002-3422-3478
Oluwagbemiga AinaBiochemistry and Nutrition Division, Nigerian Institute of Medical Research, Yaba PMB 2013, Nigeria.
Pascal MäserSwiss Tropical and Public Health Institute, Kreuzstrasse 2, CH-4123 Allschwil, Switzerland.ORCID 0000-0003-3122-1941
Ezekiel AdebiyiCovenant University Bioinformatics Research (CUBRe), Covenant University, Ota PMB 1023, Nigeria.

Funding

WEST AFRICAN SUSTAINABLE LEADERSHIP AND INNOVATION TRAINING IN BIOINFORMATICS RESEARCH (WASLITBRe)U2RTW010679 · FIC · COVENANT UNIVERSITY · PI ADEBIYI, EZEKIEL FEMI, AMOAKO-YIRENKYI, PETER · 2017 to 2021
$1.4M
FIC NIH HHS U2R TW010679NIH HHS U2RTW010679-02
6 · The paper itself

Abstract

New chemical entities are constantly being investigated towards antimalarial drug discovery, and they require animal models for toxicity and efficacy testing. Murine models show physiological similarities to humans and are therefore indispensable in the search for novel antimalarial drugs. They provide a preclinical basis (following in vitro assessments of newly identified lead compounds) for further assessment in the drug development pipeline. Specific mouse strains, non-humanized and humanized, have successfully been infected with rodent

Indexed as

antimalariadrug discoveryefficacy assessmentsmurine modelspharmacokinetics

Identifiers

PMID40143200
PMCPMC11944934

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.